Are the Newer Carbapenems of Any Value against Tuberculosis

Our aim was to assess whether newer carbapenems with a better administration profile than meropenem (ertapenem, faropenem and tebipenem) were more effective against <i>Mycobacterium tuberculosis</i> including M/XDRTB and determine if there was a synergistic/antagonistic effect with amoxi...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Ximena Gonzalo (Author), Francis Drobniewski (Author)
Formato: Libro
Publicado: MDPI AG, 2022-08-01T00:00:00Z.
Subjects:
Acceso en liña:Connect to this object online.
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Internet

Connect to this object online.

3rd Floor Main Library

Detalle de Existencias desde 3rd Floor Main Library
Número de Clasificación: A1234.567
Copia 1 Dispoñible